Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study.

MLA

Soares, Ricardo Machado, et al. “Real-World Evidence of the Long-Term Effectiveness of 0.2 Μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study.” Clinical Ophthalmology, vol. 18, Apr. 2024, pp. 1057–66. EBSCOhost, https://doi.org/10.2147/OPTH.S382920.

APA

Soares, R. M., Ferreira, C. C., da Silva Fernandes, J., Madeira, C., Silva, L. M., Saraiva, E., Ribeiro, L., & Fonseca, S. (2024). Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study. Clinical Ophthalmology, 18, 1057–1066. https://doi.org/10.2147/OPTH.S382920

Chicago

Soares, Ricardo Machado, Catarina Cunha Ferreira, Joana da Silva Fernandes, Carolina Madeira, Luís MA Silva, Eduardo Saraiva, Lígia Ribeiro, and Sofia Fonseca. 2024. “Real-World Evidence of the Long-Term Effectiveness of 0.2 Μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema – A Single Center Study.” Clinical Ophthalmology 18 (April): 1057–66. doi:10.2147/OPTH.S382920.